Epitalon vs FOXO4-DRI
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Epitalon
Telomerase-stimulating tetrapeptide
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Southern Aminos US | B- | Operational | $24.75 On sale | $2.48 | In stock | Buy with code → | |
| S1 Research (Step One Ventures) US | C | Watch | $25.00 On sale ▲ 1.0% | $2.50 | In stock | Visit → | |
| One Day Compounds US | B- | Operational | $25.99 On sale ▲ 5.0% | $2.60 | In stock | Visit → | |
| Glacier Aminos US | B | Operational | $29.69 On sale ▲ 20.0% | $2.97 | In stock | Visit → | |
| Modified Aminos US | B- | Watch | $29.99 ▲ 21.2% | $3.00 | In stock | Visit → | |
| Welli Labs US | B | Operational | $29.99 ▲ 21.2% | $3.00 | In stock | Visit → | |
| Purus Peptides US | B- | Operational | $32.00 ▲ 29.3% | $3.20 | In stock | Visit → | |
| Modern Research Peptides (.net) US | B- | Watch | $32.99 ▲ 33.3% | $3.30 | In stock | Visit → | |
| Research Peptides Europe EU | A | Operational | $36.71 ▲ 48.3% | $3.67 | In stock | Visit → | |
| Ameano Peptides US | B- | Watch | $38.00 ▲ 53.5% | $3.80 | In stock | Visit → | |
| EZ Peptides US | B | Operational | $38.00 ▲ 53.5% | $3.80 | In stock | Visit → | |
| Research Peptides US | B | Operational | $48.99 ▲ 97.9% | $4.90 | In stock | Visit → | |
| Ascension Peptides US | B | Operational | $50.00 On sale ▲ 102.0% | $5.00 | In stock | Visit → |
FOXO4-DRI
Senolytic peptide
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Valor Peptides US | B- | Operational | $79.00 ◎ Best $/mg | $15.80 | In stock | Buy with code → |
About Epitalon
Epitalon is a Khavinson tetrapeptide bioregulator (Ala-Glu-Asp-Gly / AEDG) modelled after the pineal-gland extract epithalamin in Russian gerontology research. It has been studied in animal and cell-culture models for telomerase activity, lifespan extension, and pineal-axis ageing parameters, and serves as the most widely cited member of the Khavinson short-peptide bioregulator panel alongside Pinealon, Cortagen, and the organ-targeted tetrapeptides. Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.
About FOXO4-DRI
A D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction, studied for selective clearance of senescent cells.